SEC CIK 1297709

Novartis Bioventures Ltd

Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ALTview stock →8,345,1452018-09-12
ARPOview stock →4,049,8042019-04-26
GRTXview stock →2,467,9612020-06-19
ALRNview stock →2,079,3942019-04-01
BCYCview stock →1,769,6412019-05-28
AKUSview stock →1,181,2582020-06-30

Position History — ALRN

Reported shares owned immediately after each Form 4 transaction, over time.

0833,5941,667,1882,500,7822018-072018-072018-082018-082018-082019-032019-04

Recent Filings — ALRN

DateActivitySharesPriceOwned After
2019-04-01Open-market sale20,610$1.902,079,394
2019-03-29Open-market sale106,540$1.852,100,004
2019-03-15Open-market sale43,800$1.922,206,544
2019-03-14Open-market sale13,800$1.882,250,344
2019-03-13Open-market sale132,738$2.122,264,144
2018-08-20Open-market sale20,388$2.302,396,882
2018-08-17Open-market sale8,700$2.102,417,270
2018-08-16Open-market sale8,808$2.102,425,970
2018-08-15Open-market sale2,635$2.152,434,778
2018-08-14Open-market sale3,300$2.262,437,413
2018-08-13Open-market sale1,600$2.362,440,713
2018-08-10Open-market sale5,615$2.442,442,313
2018-08-09Open-market sale235$2.482,447,928
2018-08-08Open-market sale1,000$2.782,448,163
2018-08-07Open-market sale1,739$2.972,449,163
2018-08-06Open-market sale2,942$3.022,450,902
2018-08-02Open-market sale4,702$3.332,453,844
2018-08-01Open-market sale8,181$3.222,458,546
2018-07-31Open-market sale4,500$3.072,466,727
2018-07-30Open-market sale2,000$3.272,471,227
2018-07-27Open-market sale6,458$3.382,473,227
2018-07-26Open-market sale7,937$3.632,479,685
2018-07-25Open-market sale12,460$3.842,487,622
2018-07-24Open-market sale700$4.112,500,082
2018-07-23Open-market sale30,600$4.252,500,782

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.